Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Fine needle aspirations of breast carcinomas, submitted to a hypochromic Papanicolaou staining procedure, provides useful prognostic data. Three grades of increasing severity were used as a classification. An homogeneous group of 189 patients submitted to similar therapeutic management has been analyzed: 15.3/1 000 patients/months of those classified in grade III, versus 5.2 in grade II and 2 in grade I have had a worsening outcome within 1 to 5 years. The correlation of the cytoprognostic classification with TNM classification and lymph node involvement is significant. Moreover grade III points at patients with high metastatic potential: 27 per cent of stage I, 18 per cent without lymph nodes involvement and 23 per cent with less than 3 lymph nodes involved will develop recurrence within 5 years. The absence of steroid receptors confirms the poor prognosis of grade III.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!